ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Retroperitoneal Fibrosis

  • Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis
  • The Effect and Safety of Tocilizumab Treatment on IRPF
  • A Prospective Study of Cyclophosphamide Treatment for Idiopathic Retroperitoneal Fibrosis
  • A Prospective Study of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis
  • Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis
  • Atorvastatin as an Adjunct to DFDBA in Intrabony Defects
  • Treatment of IgG4-Related Disease With Revlimid and Rituximab
  • Rituximab in IgG4-RD: A Phase 1-2 Trial
  • Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
  • Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group